The document discusses Joe Biden's metastatic prostate cancer diagnosis and the controversy surrounding PSA testing. It highlights the debate between the benefits of early detection and the risks of overdiagnosis and overtreatment. The article emphasizes the importance of transparent communication about health issues and the role of medical advisory panels in discouraging widespread PSA testing. It also references historical examples, such as Reagan's colon cancer and Betty Ford's substance use disclosure, to show how public figures' health struggles can promote public health awareness. The piece critiques the lack of transparency regarding Biden's PSA testing since 2014 and suggests that political considerations may have influenced the decision to avoid screening. The author advocates for early diagnosis, even without proven clinical benefits, to allow patients and families to plan for potential outcomes. The article aligns with a center point of view, advocating for informed public discussion about medical issues.